Article Versions Notes

Huang H-E, Lin K-M, Lin J-C, Lin Y-T, He H-R, Wang Y-W, Yu S-F, Chen J-F, Cheng T-T. Danazol in Refractory Autoimmune Hemolytic Anemia or Immune Thrombocytopenia: A Case Series Report and Literature Review. Pharmaceuticals. 2022; 15(11):1377. https://doi.org/10.3390/ph15111377

Huang, Hsu-En, Ko-Ming Lin, Jing-Chi Lin, Yu-Ting Lin, Hsiao-Ru He, Yu-Wei Wang, Shan-Fu Yu, Jia-Feng Chen, and Tien-Tsai Cheng. 2022. "Danazol in Refractory Autoimmune Hemolytic Anemia or Immune Thrombocytopenia: A Case Series Report and Literature Review" Pharmaceuticals 15, no. 11: 1377. https://doi.org/10.3390/ph15111377

Huang, H.-E., Lin, K.-M., Lin, J.-C., Lin, Y.-T., He, H.-R., Wang, Y.-W., Yu, S.-F., Chen, J.-F., & Cheng, T.-T. (2022). Danazol in Refractory Autoimmune Hemolytic Anemia or Immune Thrombocytopenia: A Case Series Report and Literature Review. Pharmaceuticals, 15(11), 1377. https://doi.org/10.3390/ph15111377